NGM Clinical Study Site 112 — San Clemente, California

NGM Clinical Study Site 112 is a clinical research site located in San Clemente, California, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

NGM Clinical Study Site 112 has participated in 1 clinical trials.

Therapeutic areas: Primary Sclerosing Cholangitis.

Sponsors: NGM Biopharmaceuticals, Inc.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NGM Clinical Study Site 112?

NGM Clinical Study Site 112 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NGM Clinical Study Site 112 conducted?

NGM Clinical Study Site 112 has 1 clinical trials on record. Their work covers Primary Sclerosing Cholangitis.

Is NGM Clinical Study Site 112 accredited by Crixeo Health?

NGM Clinical Study Site 112 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NGM Clinical Study Site 112?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.